Notice of AGM and Annual Report

e-Therapeutics plc

('e-Therapeutics' or 'the Company')

Notice of Annual General Meeting and Annual Report

Oxford and Newcastle, UK, 7 May 2015 - e-Therapeutics plc's (AIM: ETX) annual report and accounts for the year ended 31 January 2015, which includes the notice convening the Company's 2015 Annual General Meeting (AGM), has been posted to shareholders today.

The annual report can be downloaded from the Company's website at http://www.etherapeutics.co.uk/Investor-Relations/reports-and-accounts.html.

The 2015 AGM will take place at 10:30am on 11 June 2015 at the offices of Bond Dickinson LLP, St Ann's Wharf, 112 Quayside, Newcastle upon Tyne, NE1 3DX.

-Ends-

Contacts:

e-Therapeutics plc

Malcolm Young, CEO / Steve Medlicott, Finance Director

Tel: +44 (0)1993 883 125

www.etherapeutics.co.uk 

N+1 Singer

Aubrey Powell / Jen Boorer

Tel: +44 (0) 20 7496 3000

www.n1singer.com

Instinctif Partners

Melanie Toyne Sewell / Jayne Crook / Emma Barlow

Tel: +44 (0) 20 7457 2020

Email: e-therapeutics@instinctif.com

About e-Therapeutics plc

e-Therapeutics is an AIM-quoted drug discovery and development company with a proprietary platform in network pharmacology, an innovative new approach to drug discovery based on advances in network science and chemical biology. The Company's discovery and development activity is currently focused in cancer and disorders of the nervous system.

e-Therapeutics is based at sites in Oxford and Newcastle, UK. For more information about the Company, please visit www.etherapeutics.co.uk.